PRESS RELEASE
21 October 2019

Mitigating International Legal Risks Presented In Life Sciences IP Due Diligence Investigations

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Janet Xiao and Sylvia Georges Evangelinos, Senior Patent Attorney Novartis Institutes for BioMedical Research (NIBR) will speak on: Conducting a baseline international ...
United States

ACI's 3rd Annual Summit on Life Sciences IP Due Diligence

11/15/2019 11:15 a.m. - 12:00 p.m.

Life Sciences + Healthcare and IP Due Diligence

OMNI Parker House

60 School St

Boston, MA 02108

Janet Xiao

Speaking Engagement

Register

Janet Xiao and Sylvia Georges Evangelinos, Senior Patent Attorney Novartis Institutes for BioMedical Research (NIBR) will speak on: Conducting a baseline international legal risk assessment and finding and utilizing appropriate resources for your IP due diligence examination

  • Identifying potential antitrust and CFIUS risks and adjusting your IP due diligence checklist
  • Tips for the IP due diligence team including identifying wants/needs/must-haves and deal-breakers
  • What to do if legal concerns are uncovered
  • Protecting yourself in the definitive agreements
  • Incorporating lessons from the diligence process to facilitate ultimate integration

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More